![Mark Surfas](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Mark Surfas
Sociétés | Poste | Début | Fin |
---|---|---|---|
NeoStem Oncology LLC
![]() NeoStem Oncology LLC Pharmaceuticals: MajorHealth Technology NeoStem Oncology LLC is focused on the production and supply of clinically relevant embryonic stem cell derived human cell populations. Founded in 2005, the mission of NeoStem Oncology is to catalyze the efficient development of human therapies based on human embryonic stem cells. The key to this goal is the production and supply of clinically relevant human cell populations using a scalable, efficient and highly reproducible process. They generate human embryonic stem cell (hESC) lines, expand them to clinically and commercially useful numbers, and differentiate them at extremely high purity using fully-defined, proprietary media and GMP processes that are FDA compliant from day one. And they do this at a fraction of the cost of conventional cell manufacturing. As a result, the company can economically supply large quantities of high purity cells for its own clinical development pipeline in specific application areas. It can also supply high purity, fully characterized, clinically relevant human cell populations to companies or other institutions for development of therapies, efficacy screening or creation of toxicity profiles for candidate drugs, or experimental research. NeoStem Oncology LLC is a privately held Delaware Corporation with headquarters and research facilities in Irvine, CA. | Directeur/Membre du Conseil | 19/04/2012 | - |
Fondateur | 19/04/2012 | - | |
President | 22/12/2009 | 19/04/2012 |
Historique de carrière de Mark Surfas
Anciens postes connus de Mark Surfas
Sociétés | Poste | Début | Fin |
---|---|---|---|
GameSpy Industries, Inc.
![]() GameSpy Industries, Inc. Packaged SoftwareTechnology Services GameSpy Industries, Inc. developed software and interactive online entertainment. The company was founded in 1997 and was headquartered in San Francisco, CA. | Fondateur | - | - |
Statistiques
Internationale
Etats-Unis | 3 |
Opérationnelle
Founder | 2 |
Director/Board Member | 1 |
President | 1 |
Sectorielle
Health Technology | 2 |
Technology Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
NeoStem Oncology LLC
![]() NeoStem Oncology LLC Pharmaceuticals: MajorHealth Technology NeoStem Oncology LLC is focused on the production and supply of clinically relevant embryonic stem cell derived human cell populations. Founded in 2005, the mission of NeoStem Oncology is to catalyze the efficient development of human therapies based on human embryonic stem cells. The key to this goal is the production and supply of clinically relevant human cell populations using a scalable, efficient and highly reproducible process. They generate human embryonic stem cell (hESC) lines, expand them to clinically and commercially useful numbers, and differentiate them at extremely high purity using fully-defined, proprietary media and GMP processes that are FDA compliant from day one. And they do this at a fraction of the cost of conventional cell manufacturing. As a result, the company can economically supply large quantities of high purity cells for its own clinical development pipeline in specific application areas. It can also supply high purity, fully characterized, clinically relevant human cell populations to companies or other institutions for development of therapies, efficacy screening or creation of toxicity profiles for candidate drugs, or experimental research. NeoStem Oncology LLC is a privately held Delaware Corporation with headquarters and research facilities in Irvine, CA. | Health Technology |
GameSpy Industries, Inc.
![]() GameSpy Industries, Inc. Packaged SoftwareTechnology Services GameSpy Industries, Inc. developed software and interactive online entertainment. The company was founded in 1997 and was headquartered in San Francisco, CA. | Technology Services |
- Bourse
- Insiders
- Mark Surfas
- Expérience